Aedifica (AED.BR)

Overall impact
C (52)

Commentary

Aedifica is an average overall performer. With a 'C' rating of 51.6 for overall impact (44th percentile compared to all companies), Aedifica ranks 26th out of 46 industry peers, behind AB Sagax, Swire, Fabege and 22 others, and ahead of Innovative Industrial Properties, learnd SE, Aroundtown and 17 others. On top material causes for Aedifica's industry (Real Estate), Aedifica performs well in Terrestrial Biodiversity (81.5 score) and performs poorly in Arts and Culture Access (22.3 score), Sanitation Access (35.6) and Affordable, Safe Housing (8.6).
Impact
Cause AED.BR
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1985
Employees
127
Sector
Real Estate
Industry
Real Estate Management & Development
Sub-industry
Real Estate Services
SASB industry
Real Estate Services
Headquarters
Belgium
Share classes
AED.BR
Description
Aedifica is a regulated real estate company under Belgian law specializing in European healthcare real estate and more particularly in healthcare real estate elderly people. Aedifica has developed a portfolio of more than 600 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland and Spain, worth more than "6.1 billion. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following codes: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been part of the BEL20, the main stock market index of EuronextBrussels. In addition, since 2023, Aedifica has been part of the BEL ESG, the index that tracks the most performing well on ESG criteria. Aedific is part of the ERRA, StoxxEurope600 and GPR. Its market capitalization was approximately "3.3 billion as of April 29, 2025.
Material causes
Ethos considers the following causes material for Aedifica, based on its industry sub-industry Real Estate Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.